Why the study?
STEMI causes significant mortality leading to loss of productive life years, especially in younger patients, prompting a comparison of characteristics and outcomes between young and older patients undergoing PPCI.
Does young age (<50 years) compared to older age (≥50 years) affect characteristics and 1-year mortality in patients with STEMI undergoing primary PCI?
Does young age (<50 years) compared to older age (≥50 years) affect characteristics and 1-year mortality in patients with STEMI undergoing primary PCI?
Young patients with STEMI undergoing primary PCI have distinct risk factor profiles (more often male, smokers, Indian ethnicity, family history of IHD) and lower, but not negligible, 1-year mortality compared to older patients.
Younger STEMI patients may warrant focused prevention; leaves open whether age-tailored PPCI strategies improve outcomes in multiethnic populations.
OBJECTIVE: ST segment elevation myocardial infarction (STEMI) is associated with significant mortality leading to loss of productive life years, especially in younger patients. This study aims to compare the characteristics and outcomes of young versus older patients with STEMI undergoing primary percutaneous coronary intervention (PPCI) to help focus public health efforts in STEMI prevention. METHODS: Data from the Coronary Care Unit database of the National University Hospital, Singapore from July 2015 to June 2019 were reviewed. Patients were divided into young (<50 years old) or older (≥50 years old) groups. RESULTS: Of the 1818 consecutive patients with STEMI who underwent PPCI, 465 (25.6%) were <50 years old. Young compared with older patients were more likely to be male, current smokers, of Indian ethnicity, have family history of ischaemic heart disease (IHD) and had lower 1 year mortality (3.4% vs 10.4%, p<0.0001). Although diabetes, hypertension or dyslipidaemia was less common among young patients, the prevalence of having any one of these risk factors was high in the range of 28% to 38%. Age was an independent predictor of mortality in the older but not younger patients with STEMI, and diabetes showed a trend towards mortality in both groups. CONCLUSION: Young patients with STEMI are more often smokers, of Indian ethnicity and had family history of IHD, although cardiometabolic risk factors are also prevalent. Mortality is lower, but not negligible, among the young patients with STEMI. Public health efforts are needed to reduce the prevalence of these risk factors among the constitutionally susceptible population.
No takes yet. Share an insight, caveat, or question.
Tung et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: